Jane Street
LYRA

Jane Street’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Jane Street’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-880
Closed -$5.56K – 10366
2025
Q1 		$5.56K Buy
+880
New +$8.23K ﹤0.01% 9234
2024
Q4 		– Sell
-1,092
Closed -$14K – 10076
2024
Q3 		$14K Buy
1,092
+238
+28% +$3.5K ﹤0.01% 9326
2024
Q2 		$11.8K Sell
854
-2,300
-73% -$260K ﹤0.01% 9093
2024
Q1 		$981K Buy
3,154
+1,589
+102% +$423K ﹤0.01% 5449
2023
Q4 		$410K Buy
+1,565
New +$283K ﹤0.01% 7111

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's LYRA Position: Q2 2025 in Review

Jane Street sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 880 shares — an estimated $5.56K sold.

Jane Street first reported a position in LYRA in Q4 2023 and held it in 5 quarters. The position peaked at $981K in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Jane Street reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 880 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $5.56K.
  • Jane Street first reported a position in LYRA THERAPEUTICS INC in Q4 2023 and held it in 5 quarters.
  • Jane Street's LYRA THERAPEUTICS INC position peaked at $981K in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.